Dynamic and Flexible Fullstack NGS Pipelines in VSWarehouse 3

vswarehouse Logo

About this webinar

March 19, 2025 // 12:00 EST

Presented By: Jennifer Dankoff & Solomon Reinman, Field Application Scientists

As clinical variant analysis grows in complexity, laboratories face challenges in unifying diverse pipelines, optimizing infrastructure, and ensuring seamless collaboration between bioinformaticians and clinicians. In this webcast, we explore how VarSeq and VSWarehouse 3 (WH3) provide a scalable and customizable solution to integrate secondary and tertiary analysis pipelines within a single workspace.
Through real-world examples, we will demonstrate how WH3 enables flexible deployment, whether on-premises, in the cloud, or hybrid, to accommodate a variety of workflows, from whole-genome sequencing (WGS) trios to high-throughput panel processing. Attendees will gain insights into:

  • Unifying disparate secondary analysis pipelines in WH3 for a streamlined workflow.
  • Customizing pipelines with user-defined inputs, modular steps, and external tool integration.
  • Leveraging WH3’s infrastructure flexibility to optimize performance for specific project needs.
  • Seamlessly connecting secondary pipelines to tertiary analysis for efficient variant interpretation.

  • Watch as we showcase how WH3 empowers clinical labs with the adaptability and scalability needed to meet the evolving demands of genomic analysis.

    Watch on demand

    Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

    Download the slide deck

    To download a copy of the slides, visit our SlideShare page. From there, you can browse through our presentations and either clip your favorite slides or download the entire deck directly to your computer.

    -->

    Love this webcast? Check out more!

    Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.